News

The NYSCF Research Institute and the CMTA announced that the stem cell lines resulting from a collaboration that began in 2014 will now be available for use by other researchers in the largest and first-ever initiative of its kind.

A new mobile app developed by the Rare Diseases Clinical Research Network (RDCRN) makes it easier than ever for CMT patients to sign up for and navigate the network’s patient registry, which will play a key role in identifying patients ...

The CMTA Board of Directors announced May 15 the appointment of Amy J. Gray as the new chief executive officer of the Charcot-Marie-Tooth Association.

The MDA and the CMTA have formed a partnership aimed at advancing CMT research, therapy development and clinical care, while also increasing awareness and understanding of CMT by improving education for patients, medical professionals and the public.

The MDA and the CMTA today announced a research grant totaling $119,999 to Kleopas Kleopa, MD, for a study on the effectiveness of a gene therapy approach in the second most common form of Charcot-Marie-Tooth disease (CMT).